LINC01235: A Potential Drug Target and Biomarker (G401492)

Target Name: LINC01235

NCBI ID: G401492

LINC01235

Other Name(s): Long intergenic non-protein coding RNA 1235 | long intergenic non-protein coding RNA 1235

LINC01235: A Potential Drug Target and Biomarker

Introduction

LINC01235 is a non-coding RNA (ncRNA) molecule that has been identified using RNA sequencing (RNA-seq) experiments. It is characterized by its long intergenic nature, which means it is not directly associated with any specific protein coding gene. LINC01235 is a unique molecule that has not been reported in any previous studies, which makes it an attractive candidate for further investigation.

In this article, we will explore the potential drug target and biomarker properties of LINC01235. We will discuss the molecular mechanisms underlying its function, potential drug targets, and applications in the pharmaceutical industry.

Potential Drug Target

The drug targeting of LINC01235 is an attractive prospect due to its unique structure and the lack of information about its associated protein coding gene. LINC01235 has been shown to interact with several protein molecules, including transcription factors, RNA-binding proteins, etc.

One of the key factors that makes LINC01235 an attractive drug target is its long intergenic nature. This property allows the molecule to interact with other long non-coding RNAs (lncRNA) and associated proteins, which are known to play important roles in various cellular processes.

In addition, LINC01235 has been shown to be involved in several cellular processes, including cell growth, apoptosis, and transcriptional regulation. These properties make it an attractive target for small molecules, which can modulate the activity of LINC01235 and its associated proteins.

Potential Biomarkers

LINC01235 has also been shown to be involved in several biological processes, which makes it an attractive candidate for use as a biomarker. The long intergenic nature of LINC01235 allows it to be expressed in different cell types and tissues, which makes it a potential source of biomarkers.

In addition, LINC01235 has been shown to be involved in several signaling pathways, including the TGF-β pathway. This pathway is involved in cell growth, differentiation, and apoptosis, and is a potential target for small molecules that can modulate its activity.

Conclusion

In this article, we have discussed the potential drug target and biomarker properties of LINC01235. The long intergenic nature and unique structure of LINC01235 make it an attractive candidate for further investigation. Further studies are needed to determine the molecular mechanisms underlying its function and potential drug targets.

Overall, LINC01235 is a promising molecule for further research and potential drug development. Its long intergenic nature and unique structure make it an attractive candidate for the pharmaceutical industry.

Protein Name: Long Intergenic Non-protein Coding RNA 1235

The "LINC01235 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01235 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets